DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

MD Anderson Cancer Center 

500 Renaissance Drive

St. Joseph  Michigan  49085  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS










 Company News
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announce Interview Of MD Anderson Cancer Center's Dr. Elizabeth Mittendorf, Principal Investigator On Company's AE37 Phase IIb Breast Cancer Efficacy Trial 6/13/2014 12:45:03 PM
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announce Interview Of MD Anderson Cancer Center's Dr. Elizabeth Mittendorf, Principal Investigator On Company's AE37 Phase IIb Breast Cancer Efficacy Trial 6/12/2014 8:21:57 AM
Carbon Nanotubes Purified/Modified To Deliver Chemo To Pancreatic Cancer Cells, Rice University And MD Anderson Cancer Center Study 6/10/2014 7:52:20 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Presentation Of Positive Updated Results From Ongoing MD Anderson Cancer Center-Sponsored Trial Of Vosaroxin In AML And High-Risk MDS At American Society of Clinical Oncology 2014 Annual Meeting 6/2/2014 10:06:35 AM
Like MedImmune (AZN), GlaxoSmithKline (GSK) Takes Aim At Cancer In MD Anderson Cancer Center's Moon Shots Program 4/9/2014 10:46:34 AM
Ambit Biosciences Announces Initiation Of Phase 2 Cohort In MD Anderson Cancer Center Sponsored Study Of Quizartinib In AML And High Risk MDS 4/7/2014 10:01:29 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces MD Anderson Cancer Center Sponsored Trial Of Vosaroxin In AML And High-Risk MDS Poster To Be Presented At American Association for Cancer Research 2014 4/2/2014 8:53:57 AM
MedImmune (AZN), MD Anderson Cancer Center Agree To Launch Moon Shot At Cancer 3/19/2014 8:38:50 AM
Manhattan Scientifics, Inc. Announces Collaboration With MD Anderson Cancer Center To Validate New Instrument For Very Early Detection Of Cancer 1/27/2014 10:05:11 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Initiation of Phase 2 Cohort of MD Anderson Cancer Center Sponsored Study of Vosaroxin in AML and High-Risk MDS 10/30/2013 8:04:48 AM
12345